Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma

Lin-Quan Tang, Chao-Feng Li, Jing Li, +30

JNCI Journal of the National Cancer Institute

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

Lin-Quan Tang, Dong-Ping Chen, Ling Guo, +35

The Lancet Oncology

Concurrent ChemoradiotherapyNedaplatin Versus CisplatinMedicineRandomised Phase 3Metronomic Therapy +8

Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy

An-Chuan Li, Weiwei Xiao, Guan-Zhu Shen, +8

Oncotarget

OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis

Muping Di, Jingjing Miao, Qiuzhong Pan, +15

Journal of Experimental & Clinical Cancer Research

The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy

Jingjing Miao, Weiwei Xiao, Lin Wang, +5

Journal of Cancer Research and Clinical Oncology

OncologyPrognostic Nutritional IndexCancer ManagementIntensity-modulated RadiotherapyCancer Registration +5

Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study

Chong Zhao, Jingjing Miao, Yi-Jun Hua, +10

International Journal of Radiation Oncology*Biology*Physics

Locoregional ControlRadiation TherapyMild Late ToxicityMedicineNasopharyngeal Cancer +6

Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Jingjing Miao, Lin Wang, Sze Huey Tan, +19

JAMA Oncology

Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma

Wang‐Zhong Li, Xing Lv, Dan Hu, +31

JAMA Oncology

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck

Alec Vaezi, XiaoZhe Wang, Shama Buch, +9

Clinical Cancer Research

Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area

Yan‐Qun Xiang, Xing Lv, Chang-Qing Xie, +16

European Journal of Cancer

OncologyRadiation TherapyEndemic AreaCancer ManagementNasopharyngeal Cancer +5